Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.41 | 35.89 |
| PEG Ratio (TTM) | 3.12 | 10.65 |
| P/S Ratio (TTM) | 2.26 | 4.06 |
| P/B Ratio (TTM) | 1.57 | 4.05 |
| P/FCF Ratio (TTM) | 13.71 | 38.96 |
| Price to 5YR AVG Earnings Ratio | 23.31 | 81.15 |
| Price to 5YR AVG FCF Ratio | -80.47 | 54.11 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.37% | 4.16% |
| ROE (TTM) | 15.95% | 22.31% |
| Net Profit Margin (TTM) | 21.50% | -28.99% |
| ROIC 5YR AVG | 15.17% | 10.46% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 17.56% | 660.21% | 456.08% |
| Revenue | -9.50% | 11.17% | 16.75% |
| Net Income | 18.11% | 675.52% | 466.64% |
| Cash Flow | 153.20% | -9.06% | -344.20% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.65 | 1.65 |
| Quick Ratio (TTM) | 3.23 | 1.12 |
| D/E Ratio (TTM) | 0.18 | -0.01 |
| Interest Coverage (TTM) | 58.12 | 8.15 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.87 | 3.41 |
| LTL to 5YR AVG FCF | -8.74 | 5.39 |
| Shares Outstanding Growth 5YR AVG | 7.32% | 5.20% |